CanSino Biologics, Inc. (CASBF)
3.86
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
CanSino Biologics Shareholders Equity (Quarterly) : 713.05M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -25.73M |
| Zai Lab Ltd. | 662.00M |
| Ascletis Pharma, Inc. | -- |
| CStone Pharmaceuticals Co. Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.012B |
| Total Liabilities (Quarterly) | 298.95M |
| Debt to Equity Ratio | 0.2358 |
| Current Ratio | 4.107 |
| Net Debt Paydown Yield | 2.27% |